Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

Efforts to Develop KRAS Inhibitors

2017; Cold Spring Harbor Laboratory Press; Volume: 8; Issue: 7 Linguagem: Inglês

10.1101/cshperspect.a031864

ISSN

2472-5412

Autores

Matthew Holderfield,

Tópico(s)

PI3K/AKT/mTOR signaling in cancer

Resumo

Matthew Holderfield NCI-Ras Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland 21702 Correspondence: matthew.holderfield{at}nih.gov

Referência(s)